SCHEMBL10109309

SCHEMBL10109309

O=C(NCCN1CCNCC1)c1ccc2[nH]nnc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.51
SUV39H1 O43463 1/20 0.51
PRMT1 Q99873 1/20 0.51
SMYD3 Q9H7B4 1/20 0.51
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
HSD17B10 Q99714 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
HTR4 Q13639 1/20 0.46
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HASPIN Q8TF76 3/20 0.45
RAD52 P43351 2/20 0.45
HTR1A P08908 1/20 0.44
GALK1 P51570 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811540 0.88 POLB (0.60) PARP1KDM4EHTR1APOLBHPGD
SCHEMBL16240046 0.88 KMT2A (0.48) PARP1KMT2AMEN1HDAC2HDAC8
SCHEMBL14430689 0.83 KMT2A (0.60) KDM4EGAAHSD17B10L3MBTL1KMT2A
SCHEMBL2705734 0.83 ALDH1A1 (0.45) KDM4EGAAHSD17B10L3MBTL1POLB
SCHEMBL10102917 0.81 ACKR3 (0.52) KMT2AMEN1HDAC2HDAC8HDAC6
SCHEMBL13411800 0.81 NAMPT (0.39) PARP1KDM4EGAAHSD17B10KMT2A
SCHEMBL357528 0.80 NAMPT (0.47) KMT2AHTR1APOLB
SCHEMBL22064075 0.80 ALDH1A1 (0.61) KDM4EGAAHSD17B10L3MBTL1KMT2A
SCHEMBL5402078 0.80 ROCK2 (0.53) PARP1SUV39H1PRMT1SMYD3KDM4E
SCHEMBL16069982 0.79 KMT2A (0.47) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414327-B1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2014-11-19 EP disclosed
US-8841324-B2 Heterocyclic compounds as autotaxin inhibitors MERCK PATENT GMBH (DE) 2014-09-23 US disclosed
US-20120015959-A1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015959-A1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS ENPP2, HAX1, MTX1 PARP1 468/4885SUV39H1 2210/4885PRMT1 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.